Has anyone recovered after taking osimertinib/osimertinib?
Osimertinib/osimertinib (Osimertinib) is a targeted therapy for EGFR (epidermal growth factor receptor) mutation-positive advanced non-small cell lung cancer (NSCLCNSCLC pan>), clinically significant therapeutic effects have been achieved, and many patients have been cured or their conditions have been significantly controlled by using osimertinib/osimertinib.
With the continuous progress of clinical research, more and more studies have shown the effectiveness and safety of osimertinib/osimertinib in the treatment of EGFR mutation-positive NSCLC patients. In some clinical trials and real-world clinical practice, Osimertinib has been proven to significantly prolong progression-free survival (PFS) and overall survival (OS) and lead to better quality of life.

There are some case reports showing that by using osimertinib/osimertinib to treat EGFR mutation-positive NSCLC patients, some patients’ tumors have achieved complete or partial response, and their disease has been significantly controlled. After receiving osimertinib/osimertinib treatment, some patients’ tumors shrank and disappeared, and even experienced long-term disease stabilization and achieved long-term survival.
However, it should be noted that not all patients achieve complete recovery. The treatment effect will vary depending on the patient's condition, tumor characteristics, time difference before and after treatment, individual differences and other factors. Some patients may experience disease recurrence or drug resistance after treatment, requiring further treatment options.
Overall,osimertinib/osimertinibAs a targeted therapy, it has achieved significant therapeutic effects in the treatment of EGFR mutation-positive NSCLC patients. Some patients have achieved recovery or have their disease significantly controlled by using osimertinib/osimertinib. However, the treatment effect will be different for each patient, and an individualized treatment plan needs to be developed under the guidance of a doctor.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)